Onconova Therapeutics (NASDAQ:ONTX) Receives New Coverage fr

Stock analysts at StockNews.com started coverage on shares of Onconova Therapeutics (NASDAQ:ONTX – Get Free Report) in a note issued to investors on Monday. The brokerage set a “sell” rating on the biopharmaceutical company’s stock. Onconova Therapeutics Price Performance The stock has a market cap of $20.90 million, a PE ratio of -1.09 and a […]

Related Keywords

United States , , Millennium Management , Onconova Therapeutics Company Profile , Beacon Pointe Advisors , Onconova Therapeutics Inc , Renaissance Technologies , Vanguard Group Inc , Onconova Therapeutics , Get Free Report , Pointe Advisors , Vanguard Group , Onconova Therapeutics Daily , Nasdaq Ontx , Contx , Medical , Initiated Coverage , Stocknews Com ,